Assisting Doctors, Transforming Patient Care
Doctor Partnership
Dedicated Partnership with Doctors
Doctor Partnership. The new wave of drugs aimed at overcoming, and reversing obesity is delivering both exciting and significant changes in the weight-loss arena. Regulatory bodies, (NICE) in the UK, and the (FDA), in the US, have issued guidelines for those doctors prescribing GLP-1 receptor agonists, such as Wegovy and Mounjaro, for weight loss. These guidelines recommend that doctors introduce their patients to a behaviour change therapy incorporating both diet and exercise programmes. While this integrated approach holds promise for enhancing patient outcomes, it also, in some cases, presents a challenge for healthcare providers, consuming valuable doctor time and resources. At Oxford Therapeutics Limited, we offer a solution to streamline this process, resulting in a greatly reduced doctor time input, whilst enhancing patient care.
The Problem: A Strain on Healthcare Resources
The new guidelines recognise that medication alone is often insufficient for sustainable weight loss. For example, GLP-1 receptor agonists, like Wegovy and Mounjaro, have shown considerable promise in aiding weight loss. Still, their efficacy is significantly enhanced when combined with behaviour change therapy and comprehensive diet and exercise programmes. Additionally, it is noted that patients, when no longer using the prescribed weight loss drug have an elevated chance of maintaining the weight loss if they have been adhering to a programme, such as the one described on the following pages.
It is acknowledged that doctors already operate under significant time constraints, balancing numerous patients and administrative tasks. Adding the responsibility of prescribing and managing behaviour change therapies, diet plans, and exercise regimens further stretches their time and resources, along with that of their support team.
The Solution:
A Dedicated, proven online platform: We offer an innovative and efficient solution, to address this issue. Instead of doctors spending their valuable time managing every aspect of a patient’s weight-loss journey, they can simply direct patients to our dedicated online platform. The platform seamlessly delivers a proven, comprehensive, fully downloadable weight-loss programme that integrates behaviour change, diet, and exercise recommendations. There is no financial or time cost to the doctor.
How It Works
- Doctor’s Role Simplified: When prescribing GLP-1 receptor agonists, doctors simply direct their patients to a dedicated website and pass to them a specific access code linked to their practice. This code gives patients access to Oxford Therapeutics’ complete weight-loss programme.
- Patient Access: Patients visit the dedicated website, enter the code provided by their doctor, and at their convenience, download the comprehensive programme. This includes tailored behaviour change therapies, diet plans, and exercise regimens, based on the latest scientific research and clinical insights. We have included full details of the programme on the following pages of this site.
- Exclusive Benefits for Patients: Patients benefit from having unrestricted access to a proven top-tier weight loss programme, that will perfectly partner with the prescribed medication.
- Compensation for Doctors: If appropriate, doctors in the private sector can elect to be recompensed directly by Oxford Therapeutics for each patient they refer. This not only acknowledges the doctors’ efforts and time investment but also creates a mutually beneficial partnership between healthcare providers and Oxford Therapeutics. Please contact our admin team to enable us to schedule a brief call with you to discuss the many options available.
Doctor Partnership
The Advantages of the Proposed Solution
1. Efficiency and Time Management. By directing patients to a comprehensive online platform, dedicated to providing the patient with the therapies and diet/exercise required, doctors can significantly reduce their time input on each weight-loss case. This allows them to focus their time on treating their other patients, ultimately improving the overall efficiency of healthcare delivery.
2. Patient Empowerment and Engagement. Patients gain immediate and easy access to a proven weight-loss programme that they can follow at their own pace. The online nature means that patients can access resources, at any time, across any time zone, 24/7.
3. High-Quality, Evidence-Based Care. Our weight-loss programme is grounded in over 15,000 hours of 1:1 clinical treatment experience and two decades of research. Patients receive a top-performing, evidence-based programme that has been proven to deliver results. This ensures that the integration of behaviour change, diet, and exercise into their weight-loss regimen is both effective and sustainable.
4. Cost-Effective Solution. With the range of discount structures available to patients, Oxford Therapeutics makes effective weight-loss treatment affordable to everyone. Therefore, patients no longer need to face potential financial barriers to accessing comprehensive weight-loss programmes.
5. Support for Healthcare Providers. The array of available compensation options is offered in recognition of the healthcare providers role in patient care and fosters a collaborative environment between healthcare providers and Oxford Therapeutics, ultimately benefitting patients.
6. Programme Limitations. Currently, the programme is only available in ‘English’. Additionally, patients will require access to the internet to instigate the download process.
A New Standard in Weight-Loss Treatment
By addressing the practical challenges faced by healthcare professionals and providing patients with an accessible, effective, and affordable weight-loss programme, we will endeavour to transform the landscape of weight management. This approach mirrors what we have delivered to Orthopaedic Surgeons requiring an effective, pre-surgery, solution for their hip and knee replacement patients.
Case Study: Success in Action
Consider a typical scenario: A patient struggling with obesity visits their doctor and is prescribed Mounjaro. Following the new guidelines, the doctor is encouraged to recommend a behaviour change therapy, diet, and exercise plan. Instead of investing valuable time researching an acceptable plan that meets the criteria required, the doctor simply provides the patient with a dedicated code allowing them immediate access to Oxford Therapeutics’ online platform.
The patient accesses the website, enters the code, and downloads a multi-faceted, weight-loss programme. They embark on their weight-loss journey, benefitting from twelve, one-hour sessions, twelve, white-screen videos, and much more. The programme incorporates all of the components they will require. Patients are instructed to repeat all or any of the individual sessions just as often as they wish
This streamlined process not only benefits the patient by providing comprehensive support but also allows the doctor to manage their time more effectively, ultimately enhancing the quality of care they can provide to all their patients.
Doctor Partnership
Conclusion: Embracing Innovation for Better Health Outcomes
In a world where healthcare resources are increasingly stretched, innovative solutions, like the one provided by Oxford Therapeutics, are crucial. By leveraging technology and expertise, we offer a practical, effective, and mutually beneficial approach to weight-loss interventions. Doctors can efficiently manage their workload while ensuring patients receive the comprehensive care they need. Patients, in turn, benefit from accessible, proven programmes that support sustainable weight loss and overall health.
Hopefully, we are not just providing a product; we are working towards delivering a new model of healthcare assistance. By integrating behaviour change therapy, diet, and exercise with the prescription of GLP-1 receptor agonists, we are striving to establish a new standard for weight-loss treatment that promises to improve health outcomes for countless individuals.
FAQ’s
1. Who are Oxford Therapeutics Limited? Oxford Therapeutics Limited is a UK-based company. The founders have since 2024 worked around the development and distribution of behaviour change therapies, specifically designed for weight loss. The programmes are based on over 15,000 hours of 1:1 clinical treatment and more than two decades of research.
2. How does the weight-loss programme work? Our weight-loss programme is fully downloadable. It integrates behaviour change therapies, incorporating, along with many other interventions, our own recognised upgrade of CBT, (TCBT), suggested diet plans, and exercise regimens. The programme is described in detail on the following pages of this site.
3. How do patients access the weight-loss programme? The patients simply visit a dedicated website where they will be invited to enter a unique code passed to them by their doctor. The complete course can be downloaded instantly to any internet-connected device, mobile phone, laptop, or desktop computer.
4. Is there a cost for the programme? Yes, to enable us to be able to provide patient support and regular updates there is a small cost. However, patients referred by their doctors can benefit from an array of exclusive options, making it far more affordable and accessible.
5. Will I, as the patient’s doctor, be involved on an ongoing basis? No, while you provide the initial introduction/recommendation and access code, the programme is designed to be self-managed.
6. What if a patient encounters technical issues accessing the programme? In the unlikely event of any technical issues arising regarding accessibility or download problems, our customer support team is always available to assist. Patients can reach out via email, phone, or on the website’s contact form for prompt assistance.
7. In what way is this course unique? The course is built around our own upgraded version of Cognitive Behaviour Therapy, TCBT. One example of how we use this is to introduce a heightened level of awareness in patients around their historical choices and actions around food, and possibly alcohol.
‘Oxford Therapeutics Limited does not request or store any patient-client data, other than an email address for the online delivery. This information is not stored or passed to any third party.’
Oxford Therapeutics offers a selection of partnership arrangements for doctors to enhance their programme’s effectiveness and ensure seamless integration with medical personnel. This collaboration is designed to provide doctors with a simple client referral solution. Please contact us by email to allow us to schedule a brief call to discuss and share with you the range of options.
Doctor Partnership
Comprehensive Weight-Loss Programme
The weight-loss programme provided by Oxford Therapeutics has been built around extensive clinical experience and research. It encompasses a range of components designed to address the behavioural, nutritional, and physical aspects of weight management. One of the standout aspects of the treatment is the incorporation of our unusual underpinning technique, where each therapy, TCBT, NLP, Mindfulness etc are all underpinned by each other. The programme also incorporates guidelines around diet and exercise.
Conclusion
Oxford Therapeutics Limited has gained respect in the field of weight management, offering a comprehensive and evidence-based programme that is both accessible and effective. Through our dedicated partnership with doctors globally and the streamlined access provided to patients, we can ensure that weight management is approached holistically. The company’s innovative programme, promoted in the UK, Australia and the USA, is poised to make a significant impact on the health and well-being of patients. Doctor Partnership
